Alexander Knoll
Directeur Général chez BioGenes Gesellschaft für Biopolymere mbH
Profil
Alexander Knoll is the founder of BioGenes Gesellschaft für Biopolymere mbH, where he currently holds the title of Managing Director.
He founded the company in 1992.
Postes actifs de Alexander Knoll
| Sociétés | Poste | Début |
|---|---|---|
BioGenes Gesellschaft für Biopolymere mbH
 BioGenes Gesellschaft für Biopolymere mbH Medical/Nursing ServicesHealth Services BioGenes Gesellschaft für Biopolymere mbH specializes in the development and production of customized immunoassays, antigens and antibodies. The firm focused on the ELISA development, validation and kit production. It services include biotinylation of antibodies and search of suitable antibody pairs, testing of cross reactivities against various proteins, optimization of assay parameters including plate-coating conditions and buffers, determination of analytical assay parameters, production of complete kits or assay components in agreed quality and quantity and stability testing of the kits or assay components, permanent quality control of all components. The firm provides additionally the business develops custom host cell protein assays, include project design and management in cooperation with the customer, in-house antibody development and characterization with 2D analysis, ELISA and Western Blot and development of HCP assays in buffer solution and working matrices. The company was founded in 1992 and is headquartered in Berlin, Germany. | Directeur Général | 01/01/1992 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
BioGenes Gesellschaft für Biopolymere mbH
BioGenes Gesellschaft für Biopolymere mbH Medical/Nursing ServicesHealth Services BioGenes Gesellschaft für Biopolymere mbH specializes in the development and production of customized immunoassays, antigens and antibodies. The firm focused on the ELISA development, validation and kit production. It services include biotinylation of antibodies and search of suitable antibody pairs, testing of cross reactivities against various proteins, optimization of assay parameters including plate-coating conditions and buffers, determination of analytical assay parameters, production of complete kits or assay components in agreed quality and quantity and stability testing of the kits or assay components, permanent quality control of all components. The firm provides additionally the business develops custom host cell protein assays, include project design and management in cooperation with the customer, in-house antibody development and characterization with 2D analysis, ELISA and Western Blot and development of HCP assays in buffer solution and working matrices. The company was founded in 1992 and is headquartered in Berlin, Germany. | Health Services |
